| 1 | A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels. (de Vries PS, Reventun P, Brown MR, Heath AS, Huffman JE, Le NQ, Bebo A, Brody JA, Temprano-Sagrera G, Raffield LM, Ozel AB, Thibord F, Jain D, Lewis JP, Rodriguez BAT, Pankratz N, Taylor KD, Polasek O, Chen MH, Yanek LR, Carrasquilla GD, Marioni RE, Kleber ME, Trégouët DA, Yao J, Li-Gao R, Joshi PK, Trompet S, Martinez-Perez A, Ghanbari M, Howard TE, Reiner AP, Arvanitis M, Ryan KA, Bartz TM, Rudan I, Faraday N, Linneberg A, Ekunwe L, Davies G, Delgado GE, Suchon P, Guo X, Rosendaal FR, Klaric L, Noordam R, van Rooij F, Curran JE, Wheeler MM, Osburn WO, O'Connell JR, Boerwinkle E, Beswick A, Psaty BM, Kolcic I, Souto JC, Becker LC, Hansen T, Doyle MF, Harris SE, Moissl AP, Deleuze JF, Rich SS, van Hylckama Vlieg A, Campbell H, Stott DJ, Soria JM, de Maat MPM, Almasy L, Brody LC, Auer PL, Mitchell BD, Ben-Shlomo Y, Fornage M, Hayward C, Mathias RA, Kilpeläinen TO, Lange LA, Cox SR, März W, Morange PE, Rotter JI, Mook-Kanamori DO, Wilson JF, van der Harst P, Jukema JW, Ikram MA, Blangero J, Kooperberg C, Desch KC, Johnson AD, Sabater-Lleal M, Lowenstein CJ, Smith NL, Morrison AC) Blood 2024 May 02;143(18):1845-1855 20 Citations |
| 1 | PD1+TIGIT+2B4+KLRG1+ Cells Might Underlie T Cell Dysfunction in Patients Treated with BCMA-Directed Chimeric Antigen Receptor T Cell Therapy. (Mishra AK, Schmidt TM, Martell EB, Chen AS, Dogru RE, Hematti P, Callander NS) Transplant Cell Ther 2024 Feb;30(2):191-202 13 Citations |
| 1 | Mitophagy protects β cells from inflammatory damage in diabetes. (Sidarala V, Pearson GL, Parekh VS, Thompson B, Christen L, Gingerich MA, Zhu J, Stromer T, Ren J, Reck EC, Chai B, Corbett JA, Mandrup-Poulsen T, Satin LS, Soleimanpour SA) JCI Insight 2020 Dec 17;5(24) 116 Citations |
| 1 | Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo. (Yang M, Kholmukhamedov A, Schulte ML, Cooley BC, Scoggins NO, Wood JP, Cameron SJ, Morrell CN, Jobe SM, Silverstein RL) Blood Adv 2018 Nov 13;2(21):2848-2861 63 Citations |
| 1 | Macrophage Transitions in Heart Valve Development and Myxomatous Valve Disease. (Hulin A, Anstine LJ, Kim AJ, Potter SJ, DeFalco T, Lincoln J, Yutzey KE) Arterioscler Thromb Vasc Biol 2018 Mar;38(3):636-644 68 Citations |
| 1 | IL17 Functions through the Novel REG3β-JAK2-STAT3 Inflammatory Pathway to Promote the Transition from Chronic Pancreatitis to Pancreatic Cancer. (Loncle C, Bonjoch L, Folch-Puy E, Lopez-Millan MB, Lac S, Molejon MI, Chuluyan E, Cordelier P, Dubus P, Lomberk G, Urrutia R, Closa D, Iovanna JL) Cancer Res 2015 Nov 15;75(22):4852-62 111 Citations |
| 2 | CLEC-2: the inside story. (Newman DK) Blood 2015 Jun 25;125(26):3972-4 3 Citations |
| 1 | Isoproterenol acts as a biased agonist of the alpha-1A-adrenoceptor that selectively activates the MAPK/ERK pathway. (Copik AJ, Baldys A, Nguyen K, Sahdeo S, Ho H, Kosaka A, Dietrich PJ, Fitch B, Raymond JR, Ford AP, Button D, Milla ME) PLoS One 2015;10(1):e0115701 34 Citations |
| 1 | Population genetics of Anopheles coluzzii immune pathways and genes. (Rottschaefer SM, Crawford JE, Riehle MM, Guelbeogo WM, Gneme A, Sagnon N, Vernick KD, Lazzaro BP) G3 (Bethesda) 2014 Dec 30;5(3):329-39 10 Citations |
| 1 | The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels. (Rydz N, Swystun LL, Notley C, Paterson AD, Riches JJ, Sponagle K, Boonyawat B, Montgomery RR, James PD, Lillicrap D) Blood 2013 Jun 27;121(26):5228-37 114 Citations |
| 1 | HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells. (Florentin J, Aouar B, Dental C, Thumann C, Firaguay G, Gondois-Rey F, Soumelis V, Baumert TF, Nunès JA, Olive D, Hirsch I, Stranska R) Blood 2012 Nov 29;120(23):4544-51 54 Citations |
| 1 | The effect of mesenchymal stromal cell-hyaluronic acid hydrogel constructs on immunophenotype of macrophages. (Hanson SE, King SN, Kim J, Chen X, Thibeault SL, Hematti P) Tissue Eng Part A 2011 Oct;17(19-20):2463-71 57 Citations |
| 1 | More CLEC16A gene variants associated with multiple sclerosis. (Nischwitz S, Cepok S, Kroner A, Wolf C, Knop M, Müller-Sarnowski F, Pfister H, Rieckmann P, Hemmer B, Ising M, Uhr M, Bettecken T, Holsboer F, Müller-Myhsok B, Weber F) Acta Neurol Scand 2011 Jun;123(6):400-6 23 Citations |
| 1 | Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. (Kim J, Hematti P) Exp Hematol 2009 Dec;37(12):1445-53 701 Citations |
| 1 | The p110 delta of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation. (Guo H, Samarakoon A, Vanhaesebroeck B, Malarkannan S) J Exp Med 2008 Sep 29;205(10):2419-35 93 Citations |
| 1 | Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice. (Mukhopadhaya A, Hanafusa T, Jarchum I, Chen YG, Iwai Y, Serreze DV, Steinman RM, Tarbell KV, DiLorenzo TP) Proc Natl Acad Sci U S A 2008 Apr 29;105(17):6374-9 124 Citations |
| 2 | Bcl10 plays a divergent role in NK cell-mediated cytotoxicity and cytokine generation. (Malarkannan S, Regunathan J, Chu H, Kutlesa S, Chen Y, Zeng H, Wen R, Wang D) J Immunol 2007 Sep 15;179(6):3752-62 38 Citations |
| 1 | Cellular immune response to an engineered cell-based tumor vaccine at the vaccination site. (Zhou Q, Johnson BD, Orentas RJ) Cell Immunol 2007 Feb;245(2):91-102 6 Citations |
| 1 | Differential and nonredundant roles of phospholipase Cgamma2 and phospholipase Cgamma1 in the terminal maturation of NK cells. (Regunathan J, Chen Y, Kutlesa S, Dai X, Bai L, Wen R, Wang D, Malarkannan S) J Immunol 2006 Oct 15;177(8):5365-76 43 Citations |
| 1 | The balancing act: inhibitory Ly49 regulate NKG2D-mediated NK cell functions. (Malarkannan S) Semin Immunol 2006 Jun;18(3):186-92 22 Citations |
| 1 | Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. (Lincoln J, Lange AW, Yutzey KE) Dev Biol 2006 Jun 15;294(2):292-302 171 Citations |
| 1 | Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. (Gantner BN, Simmons RM, Underhill DM) EMBO J 2005 Mar 23;24(6):1277-86 574 Citations |
| 1 | Functional reprogramming of the primary immune response by T cell receptor antagonism. (Haribhai D, Edwards B, Williams ML, Williams CB) J Exp Med 2004 Dec 06;200(11):1371-82 10 Citations |
| 1 | NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors. (Regunathan J, Chen Y, Wang D, Malarkannan S) Blood 2005 Jan 01;105(1):233-40 54 Citations |
| 1 | Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. (Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM) J Exp Med 2003 May 05;197(9):1107-17 1447 Citations |
| 1 | MHC class I molecules on adenovirus E1A-expressing tumor cells inhibit NK cell killing but not NK cell-mediated tumor rejection. (Routes JM, Ryan JC, Ryan S, Nakamura M) Int Immunol 2001 Oct;13(10):1301-7 5 Citations |
| 2 | Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation. (Truitt RL, Johnson BD, Hanke C, Talib S, Hearst JE) J Immunol 1999 Nov 01;163(9):5145-56 48 Citations |
| 1 | Differential quantitative effects of interleukin (IL)-2 and IL-15 on cytotoxic activity and proliferation by lymphocytes from patients receiving in vivo IL-2 therapy. (de Jong JL, Farner NL, Javorsky BR, Lindstrom MJ, Hank JA, Sondel PM) Clin Cancer Res 1998 May;4(5):1287-96 12 Citations |
| 1 | Regulation of lysosomal and ubiquitin degradative pathways in differentiating human intestinal Caco-2 cells. (Zhang Y, Wick DA, Haas AL, Seetharam B, Dahms NM) Biochim Biophys Acta 1995 May 29;1267(1):15-24 11 Citations |
